A61K 31/035
Having aliphatic unsaturation
Official title: having aliphatic unsaturation
A61K31/035 (Having aliphatic unsaturation) appears on 37 US grants and 42 published applications in this corpus.
Search patents in A61K- Granted patents
- 37
- Published applications
- 42
- Assignees
- 33
- Inventors
- 84
- Latest grant
- 22 Apr 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 5 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 0 |
| 2002 | 1 | 2 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 2 | 1 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 2 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 4 |
| 2014 | 0 | 3 |
| 2015 | 2 | 2 |
| 2016 | 1 | 1 |
| 2017 | 0 | 2 |
| 2018 | 4 | 3 |
| 2019 | 0 | 2 |
| 2020 | 2 | 5 |
| 2021 | 1 | 2 |
| 2022 | 1 | 1 |
| 2023 | 2 | 3 |
| 2024 | 2 | 2 |
| 2025 | 2 | 3 |
By publication year. Applications have been published since 2001.
Recent patents
- Composition for increasing the expression of a growth factor gene, comprising coreshell structured microparticles as active ingredient22 Apr 2025US 12,280,155 B2G&P Bioscience Co., Ltd.
- Treatment of 22Q11.2 deletion syndrome with cannabidiol7 Jan 2025US 12,186,282 B2Harmony Biosciences Management, Inc.
- Determination of personalized endocannabinoid genotypes and associated recommendations13 Feb 2024US 11,896,576 B2Endocanna Health, Inc.
- Cannabinoid formulations2 Jan 2024US 11,857,530 B2Endocanna Health, Inc.
- Methods for treating diseases20 Jun 2023US 11,679,098 B2University of Louisville Research Foundation, Inc.
- Cosmetic and non-cosmetic compositions and methods of use26 Jun 2025US 2025/0205127 A1K&K Biotech
- Treatment of 22q11.2 deletion syndrome with cannabidiol26 Jun 2025US 2025/0205174 A1Harmony Biosciences Management, Inc.
- Cannabinoid compositions for gastroesophageal disorders16 Jan 2025US 2025/0017948 A1The Brigham and Women S Hospital, Inc.
- Cannabinoid Formulations5 Sep 2024US 2024/0293356 A1Endocanna Health, Inc.
- Combination therapy for treatment of conditions associated with aging9 May 2024US 2024/0148717 A1
Most cited
By later US patents
- Method for responding to an emergency event83US 5,960,337 ATrimble Navigation Limited · 1999
- Partial liquid breathing of fluorocarbons60US 5,490,498 AAlliance Pharmaceutical Corp. · 1996
- Perfluoro polycyclic compounds for use as synthetic blood and perfusion media58US 4,105,798 AChildren's Hospital Medical Center · 1978
- Partial liquid breathing of fluorocarbons29US 5,655,521 AAlliance Pharmaceutical Corp. · 1997
- Treatment and diagnosis of respiratory disorders using fluorocarbon liquids16US 5,853,003 AAlliance Pharmaceutical Corp. · 1998